Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: The Diabetes Collaborative Registry

Diabetes, Obesity and Metabolism

Volumn 21, Issue 5, 2019, Pages 1121-1127

  Fan, Wenjun ^a   Song, Yang ^b   Inzucchi, Silvio E ^c   Sperling, Laurence ^d   Cannon, Christopher P ^b,e   Arnold, Suzanne V ^f   Kosiborod, Mikhail ^f   Wong, Nathan D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Baim Institute of Clinical Research   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f Saint Luke's Health System Missouri   (United States)

Author keywords

cardiovascular disease; prevention; risk factors; type 2 diabetes

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CAUCASIAN; CHILD; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DEPRESSION; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; SEX DIFFERENCE; SMOKING; SOCIAL STATUS; ATHEROSCLEROSIS; BLOOD; CARDIOVASCULAR DISEASE; MIDDLE AGED; PATIENT CARE PLANNING; PROGNOSIS; REGISTER; RISK FACTOR; UNITED STATES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; GLYCATED HEMOGLOBIN A; HUMANS; MALE; MIDDLE AGED; PATIENT CARE PLANNING; PROGNOSIS; REGISTRIES; RISK FACTORS; UNITED STATES;

EID: 85061577605     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.13625     Document Type: Article

References (27)

1. American Diabetes Association. Cardiovascular disease and risk management. Sec. 8. In Standards of Medical Care in Diabetes 2016. Diabetes Care. 2016;39(suppl 1):S60-S71.
2. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2000;23(suppl 1):S32-S42.
3. Wong ND, Patao C, Wong K, Malik S, Franklin SS, Iloeje U. Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: comparison by prevalent cardiovascular disease status. Diab Vasc Dis Res. 2013;10(6):505-513.
4. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348(5):383-393.
5. Wong ND, Zhao Y, Patel R, et al. Cardiovascular risk factor targets and cardiovascular disease event risk in diabetes: a pooling project of the atherosclerosis risk in communities study, multi-ethnic study of atherosclerosis, and Jackson Heart Study. Diabetes Care. 2016;39(5):668-676.
6. Arnold SV, Inzucchi SE, McGuire DK, et al. Evaluating the quality of comprehensive cardiometabolic care for patients with type 2 diabetes in the U.S.: the diabetes collaborative registry. Diabetes Care. 2016;39(7):e99-e101.
7. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;71(19):e127-e248.
8. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2889-2934.
9. Gaede P, Lund-Anderson H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358:580-591.
10. Gaede P, Oellgaard J, Carstensen B, et al. Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial. Diabetologia. 2016;59:2298-2307.
11. Bittner V, Bertolet M, Barraza Felix R, et al. Comprehensive cardiovascular risk factor control improves survival: the BARI 2D trial. J Am Coll Cardiol. 2015;66:765-773.
12. Pagidipati NJ, Navar AM, Pieper KS, et al. Secondary prevention of cardiovascular disease in patients with type 2 diabetes mellitus: international insights from the TECOS trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin). Circulation. 2017;136(13):1193-1203.
13. Hamada S, Gulliford MC. Multiple risk factor control, mortality and cardiovascular events in type 2 diabetes and chronic kidney disease: a population-based cohort study. BMJ Open. 2018;8:e019950.
14. Rawshani A, Rawshani A, Fanzen S, et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2018;379:633-644.
15. Figliuzzi I, Presta V, Citoni B, et al. Achievement of multiple therapeutic targets for cardiovascular disease prevention: retrospective analysis of real practice in Italy. Clin Cardiol. 2018;31:788-796.
16. Zuo JH, Wang WH, Deng LQ, Su JL. Control of cardiovascular disease risk factors among patients with type II diabetes in a primary care setting in Beijing. J Am Soc Hypertens. 2018;12:128-134.
17. Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB. The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care. 2004;27:1879-1884.
18. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA. 1991;265(5):627-631.
19. Juutilainen A, Kortelainen S, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care. 2004;27:2898-2904.
20. Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J, Hu G. Sex differences in the risk of stroke and HbA(1c) among diabetic patients. Diabetologia. 2014;57(5):918-926.
21. Wexler DJ, Grant RW, Meigs JB, Nathan DM, Cagliero E. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care. 2005;28:514-520.
22. Age-Adjusted Percentage of People with Diabetes Aged 35 Years or Older Reporting Heart Disease or Stroke, by Race/Ethnicity, United States, 1997–2011. Atlanta, GA: Centers for Disease Control and Prevention; 2012.
23. Tofler GH, Stone PH, Muller JE, et al. Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. J Am Coll Cardiol. 1987;9(3):473-482.
24. Diez-Roux AV, Nieto FJ, Tyroler HA, Crum LD, Szklo M. Social inequalities and atherosclerosis. The atherosclerosis risk in communities study. Am J Epidemiol. 1995;141:960-972.
25. Ali S, Stone MA, Peters JL, Davies MJ, Khunti K. The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2006;23(11):1165-1173. Review.
26. Scherrer JF, Garfield LD, Chrusciel T, et al. Increased risk of myocardial infarction in depressed patients with type 2 diabetes. Diabetes Care. 2011;34(8):1729-1734.
27. Katon WJ. The comorbidity of diabetes mellitus and depression. Am J Med. 2008;121(11 suppl 2):S8-S15.